The University of Chicago Header Logo

Connection

Benjamin Derman to Thalidomide

Back to Details
This is a "connection" page, showing publications Benjamin Derman has written about Thalidomide.
Benjamin Derman
Connection Strength
0.057
Thalidomide
  1. Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone. Pol Arch Intern Med. 2024 05 28; 134(5).
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.